- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
ULURU Inc. announced today that Kerry P. Gray, the company's President and Chief Executive Officer, will provide a corporate presentation at the Cowen and Company 28th Annual Health Care Conference in Boston, MA on March 20, 2008 at 11:00 a.m. Eastern time.
Interested investors and others may also listen to the presentation, hosted by Cowen and Company, live and by replay at www.corporateir.net/ireye/conflobby.zhtml?ticker=ULU&;item_id=1780912 and clicking on the link for this webcast. Access to the webcast is not password protected.
About ULURU Inc.
ULURU Inc. is an emerging specialty pharmaceutical company focused on the development of a portfolio of wound management, plastic surgery and oral care products to provide patients and consumers improved clinical outcomes through controlled delivery utilizing its innovative transmucosal delivery system and Hydrogel Nanoparticle Aggregate technology.
This press release contains certain statements that are forward-looking within the meaning of Section 27a of the Securities Act of 1933, as amended. These statements are subject to numerous risks and uncertainties, including but not limited to the risk factors detailed in the Company's Annual Report on Form 10-KSB for the year ended December 31, 2006 and other reports filed by us with the Securities and Exchange Commission.
For more information, please click here
Kerry P. Gray
President & CEO
Terry K. Wallberg
Vice President & CFO
Copyright © PR Newswire Association LLC.If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Call for NanoArt and Art-Science-Technology Papers June 9th, 2016
Novel gene therapy shows potential for lung repair in asthma May 18th, 2016